Pemphigoid Gestationis: A Retrospective Study in Southwest Iran
Pemphigoid gestationis (PG) is a rare autoimmune bullous dermatosis of pregnancy usually presents in the second or third trimester. It is characterized by pruritic, urticarial plaques with the development of tense vesicles and bullae within the lesions. Pathogenesis of PG is not fully established, however, most patients develop circulating autoantibodies targeting the bullous pemphigoid (BP) 180 antigen. The aim of this work is to draw a profile of the epidemiology, clinical aspects, treatment and evolution of the disease by studying hospital series. We retrospectively investigated the 13 patients who were diagnosed with PG based on hospital data at the Referral Center of Southwest Iran located in Ahvaz city between March 2002 and March 2011. The age of onset was 21 to 40 years (mean age: 27.5 years). The onset of the disease occurred in the second trimester of pregnancy in 6 patients and in the third trimester of pregnancy in 4 patients. One patient had a flare up of disease during the first trimester and two out of cases in puerperium period. In all cases, pruritus was the first symptom, followed by an erythematous vesiculobullous eruption. The diagnosis of PG was confirmed by skin biopsy. Ten out of the patients treated with oral corticosteroids (0.5-1 mg/kg/day), one of the patients underwent oral corticosteroids plus topical glucocorticoid and the last patient treated with topical glucocorticoid. PG remains a rare dermatosis of pregnancy. Our series had two particularities compared to other studies: high frequency in primigravida and the frequent involvement of the face. Additionally our study demonstrated that improvement could occur faster and provide acceptable management if the treatment of the patients would be implemented sooner.
Rodrigues Cdos S, Filipe P, Solana Mdel M, Soares de Almeida L, Cirne de Castro J, Gomes MM. Persistent herpes gestationis treated with high-dose intravenous immunoglobulin. Acta Derm Venereol 2007;87(2):184-6.
Sachdeva S. The dermatoses of pregnancy. Indian J Dermatol 2008;53(3):103-5.
Daneshpazhooh M, Chams-Davatchi C, Payandemehr P, Nassiri S, Valikhani M, Safai-Naraghi Z. Spectrum ofautoimmune bullous diseases in Iran: a 10-year review. Int J Dermatol 2012 ;51(1):35-41.
Cobo MF, Santi CG, Maruta CW, Aoki V. Pemphigoid gestationis: clinical and laboratory evaluation. Clinics (SaoPaulo) 2009;64(11):1043-7.
Lu PD, Ralston J, Kamino H, Stein JA. Pemphigoid gestationis. Dermatol Online J 2010;16(11):10.
Ingen-Housz-Oro S. Pemphigoid gestationis: a review. Ann Dermatol Venereol 2011;138(3):209-13.
Lipozenčić J, Ljubojevic S, Bukvić-Mokos Z. Pemphigoid gestationis. Clin Dermatol 2012;30(1):51-5.
Campbell SM, Balazs K, Conroy M. Pemphigoid gestationis: a case report and review of the literature. Cutis 2011;88(1):21-6.
Lipozenčić J, Ljubojevic S, Bukvić-Mokos Z Pemphigoid gestationis. Clin Dermatol 2012;30(1):51-5.
Scheinfeld N. Pruritic urticarial papules and plaques of pregnancy wholly abated with one week twice daily application of fluticasone propionate lotion: a case report and review of the literature. Dermatol Online J 2008;14(11):4.
Adams SP. Dermacase. Pruritic urticarial papules and plaques of pregnancy (PUPPP). Can Fam Physician 1998;44:1609-18.
Boudaya S, Turki H, Meziou TJ, Marrekchi S, Bouassida S, Zahaf A. Pemphigoid gestationis: a study of 15 cases . J Gynecol Obstet Biol Reprod (Paris) 2003;32(1):30-4
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.